Update on Glaucoma Treatment in the Field of Pharmacotherapy.
Wydanie 3/2020
str. 50 – 51
Autorzy: Ewa Mrukwa-Kominek1,2, Marta Hajduga-Szewczyk1
1. Klinika Okulistyki Katedry Okulistyki Wydziału Nauk Medycznych w Katowicach Śląskiego Uniwersytetu Medycznego w Katowicach.
Kierownik: prof. dr hab. n. med. Ewa Mrukwa-Kominek.
2. Oddział Okulistyki Dorosłych Uniwersyteckiego Centrum Klinicznego im. prof. K. Gibińskiego Śląskiego Uniwersytetu Medycznego w Katowicach.
Kierownik: prof. dr hab. n. med. Ewa Mrukwa-Kominek.
Summary:
Glaucoma is a chronic disease that can damage the optic nerve and ultimately lead to blindness. Currently, the only proven treatment method is the reduction of intraocular pressure. It is mostly pharmacological treatment. In the latest update of the „Guidelines for the diagnosis and treatment of glaucoma” of the Polish Ophthalmology Society, particular attention was paid to the presence of preservatives in ophthalmic drops. Currently, we have a lot of preparations without this component. Thanks to their use, you can reduce the side effects of drugs. In addition, you may want to consider different types of eye drop packaging. The easier it is for the patient to apply the drug, the more likely to comply with the recommendations.
Keywords: glaucoma, treatment standards, pharmacotherapy, nonpreservative drugs.
Słowa kluczowe: jaskra, standardy leczenia, farmakoterapia, krople oczne bez środków konserwujących.